The US FDA is the US agency responsible for regulating intelligent drug-delivery systems (IDDS). IDDS can be classified as a device, drug, biologic or combination product. In this perspective, the current regulatory framework for IDDS and future perspectives on how the field is expected to evolve from a regulatory standpoint is discussed.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.4155/tde.12.119 | DOI Listing |
Publication Analysis
Top Keywords
regulatory framework
8
intelligent drug-delivery
8
drug-delivery systems
8
current perspectives
4
perspectives fda
4
fda regulatory
4
framework intelligent
4
systems fda
4
fda agency
4
agency responsible
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!